Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Chastain

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Infectious Disease|June 30, 2025
Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017-2020)Sophea Chan, Laura Leigh Stoudenmire, Xianyan Chen, et al.
Emerging Infectious Diseases|October 19, 2018
Cryptococcus gattii Complex Infections in HIV-Infected Patients, Southeastern United StatesKaylee T Bruner, Carlos Franco-Paredes, Andrés F Henao-Martínez, et al.
Open Forum Infectious Diseases|June 16, 2025
Impact of Substance Use Disorders on Outcomes of Medically Insured Persons Receiving Multiweek Outpatient Parenteral Antimicrobial Therapy: a Claims-based Cohort Study From 2015 to 2020Daniel J Rogers, Lingyu Zhao, Duna Zhan, et al.
Current Infectious Disease Reports|September 9, 2019
Simplifying ARV Therapy in the Setting of ResistanceNeha Sheth Pandit, Daniel B Chastain, Andrea M Pallotta, et al.
Diagnostic Microbiology and Infectious Disease|June 29, 2021
Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremiaAmber B Clemmons, Henry N Young, Christopher M Bland, et al.
Therapeutic Advances in Infectious Disease|February 13, 2025
The impact of climate change on the epidemiology of fungal infections: implications for diagnosis, treatment, and public health strategiesMary E George, Tonisha T Gaitor, David B Cluck, et al.
Open Forum Infectious Diseases|July 22, 2020
Countermeasures to Coronavirus Disease 2019: Are Immunomodulators Rational Treatment Options-A Critical Review of the EvidenceDaniel B Chastain, Tia M Stitt, Phong T Ly, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 5, 2021
Evaluating <i>Clostridioides difficile</i> infection (CDI) treatment duration in hematology/oncology patients receiving concurrent non-CDI antibioticsKelli R Keats, Tia M Stitt, Daniel B Chastain, et al.
Open Forum Infectious Diseases|June 30, 2021
Disseminated Cryptococcal Disease in A Patient With Chronic Chylothorax and a Pleurovenous Catheter, a Case Report With Autopsy FindingsWilliam Mundo, Amber Berning, Yiannis Koullias, et al.
The Lancet. Infectious Diseases|May 11, 2020
Prevention of yellow fever in travellers: an updateElaine Reno, Nicolas G Quan, Carlos Franco-Paredes, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Infectious Disease|June 30, 2025
Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017-2020)Sophea Chan, Laura Leigh Stoudenmire, Xianyan Chen, et al.
Emerging Infectious Diseases|October 19, 2018
Cryptococcus gattii Complex Infections in HIV-Infected Patients, Southeastern United StatesKaylee T Bruner, Carlos Franco-Paredes, Andrés F Henao-Martínez, et al.
Open Forum Infectious Diseases|June 16, 2025
Impact of Substance Use Disorders on Outcomes of Medically Insured Persons Receiving Multiweek Outpatient Parenteral Antimicrobial Therapy: a Claims-based Cohort Study From 2015 to 2020Daniel J Rogers, Lingyu Zhao, Duna Zhan, et al.
Current Infectious Disease Reports|September 9, 2019
Simplifying ARV Therapy in the Setting of ResistanceNeha Sheth Pandit, Daniel B Chastain, Andrea M Pallotta, et al.
Diagnostic Microbiology and Infectious Disease|June 29, 2021
Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremiaAmber B Clemmons, Henry N Young, Christopher M Bland, et al.
Therapeutic Advances in Infectious Disease|February 13, 2025
The impact of climate change on the epidemiology of fungal infections: implications for diagnosis, treatment, and public health strategiesMary E George, Tonisha T Gaitor, David B Cluck, et al.
Open Forum Infectious Diseases|July 22, 2020
Countermeasures to Coronavirus Disease 2019: Are Immunomodulators Rational Treatment Options-A Critical Review of the EvidenceDaniel B Chastain, Tia M Stitt, Phong T Ly, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 5, 2021
Evaluating <i>Clostridioides difficile</i> infection (CDI) treatment duration in hematology/oncology patients receiving concurrent non-CDI antibioticsKelli R Keats, Tia M Stitt, Daniel B Chastain, et al.
Open Forum Infectious Diseases|June 30, 2021
Disseminated Cryptococcal Disease in A Patient With Chronic Chylothorax and a Pleurovenous Catheter, a Case Report With Autopsy FindingsWilliam Mundo, Amber Berning, Yiannis Koullias, et al.
The Lancet. Infectious Diseases|May 11, 2020
Prevention of yellow fever in travellers: an updateElaine Reno, Nicolas G Quan, Carlos Franco-Paredes, et al.
Pageof 12